Shariah compliance overview
HalalCorcept Therapeutics Incorporated (CORT) is currently classified as Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated, founded in 1998 and headquartered in Menlo Park, California, is a pharmaceutical firm dedicated to the discovery, development, and commercialization of treatments for serious metabolic, oncological, and neuropsychiatric disorders across the United States.
Corcept Therapeutics Incorporated (CORT) operates in the Healthcare sector, in the Medical - Pharmaceuticals industry.
Why it is halal: it passes all three AAOIFI screens. Non-compliant revenue is 2.77% (limit 5%), interest-bearing debt is 0.09% (limit 30%) and interest-bearing securities and assets are 6.64% (limit 30%).
If you hold CORT, give 2.77% of the dividends you receive to charity to purify the non-compliant share of its income.
- Business Activity
- 2.77%Limit 5%Pass
- Interest-bearing debt
- 0.09%Limit 30%Pass
- Interest-bearing securities and assets
- 6.64%Limit 30%Pass
- Dividend purification
- 2.77%Share of dividends to give to charityPurification calculator
Last updated: Oct 22, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Corcept Therapeutics Incorporated (CORT). Current Akinda screening label: Halal.
